10x Genomics Stock Technical Analysis
| TXG Stock | USD 27.52 0.06 0.22% |
As of the 24th of April, 10X Genomics shows the mean deviation of 2.27, and Variance of 8.11. Compared to fundamental indicators, the technical analysis model gives you tools to check timely technical drivers of 10X Genomics, as well as the relationship between them. Put another way, you can use this information to find out if the entity will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated thirteen technical drivers for 10X Genomics, which can be compared to its peers. Please confirm 10X Genomics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if 10X Genomics is priced more or less accurately, providing market reflects its regular price of 27.52 per share. Given that 10X Genomics has information ratio of (0.24), we suggest you to validate 10X Genomics's prevailing market performance to make sure the company can sustain itself sooner or later.
10X Genomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as 10X, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to 10X10X |
10X Genomics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 60.33 | Strong Buy | 15 | Odds |
Most 10X analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand 10X stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of 10X Genomics, talking to its executives and customers, or listening to 10X conference calls.
10X Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
10X Genomics Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of 10X Genomics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
10X Genomics Trend Analysis
Use this graph to draw trend lines for 10X Genomics. You can use it to identify possible trend reversals for 10X Genomics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual 10X Genomics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.10X Genomics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for 10X Genomics applied against its price change over selected period. The best fit line has a slop of 0.31 , which may imply that the returns on investment in 10X Genomics will continue to fail. It has 122 observation points and a regression sum of squares at 3680.73, which is the sum of squared deviations for the predicted 10X Genomics price change compared to its average price change.About 10X Genomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of 10X Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of 10X Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on 10X Genomics price pattern first instead of the macroeconomic environment surrounding 10X Genomics. By analyzing 10X Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of 10X Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to 10X Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 4.27 | 5.57 | 13.31 | 13.97 | Days Of Inventory On Hand | 295.41 | 247.49 | 128.47 | 140.12 |
10X Genomics April 24, 2024 Technical Indicators
Most technical analysis of 10X help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for 10X from various momentum indicators to cycle indicators. When you analyze 10X charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 2.27 | |||
| Coefficient Of Variation | (484.35) | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.11 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 12.68 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 4.58 | |||
| Skewness | 0.1927 | |||
| Kurtosis | (0.34) |
10X Genomics April 24, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as 10X stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 66,323 | ||
| Daily Balance Of Power | (0.06) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 27.45 | ||
| Day Typical Price | 27.47 | ||
| Price Action Indicator | 0.04 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 10X Genomics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for 10X Stock analysis
When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is 10X Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.18) | Revenue Per Share 5.281 | Quarterly Revenue Growth 0.178 | Return On Assets (0.12) | Return On Equity (0.33) |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.